Free Trial

Sionna Therapeutics (SION) SEC Filings & 10K Form

$20.01 +0.25 (+1.27%)
As of 02:25 PM Eastern

Recent Sionna Therapeutics SEC Filings

DateFilerForm TypeView
02/18/2025
7:56 PM
Sionna Therapeutics (Subject)
TPG GP A, LLC (Filed by)
Form SCHEDULE 13D
02/13/2025
3:47 PM
ORBIMED ADVISORS LLC (Filed by)
Sionna Therapeutics (Subject)
Form SCHEDULE 13D
02/12/2025
4:21 PM
COULTER JAMES G (Reporting)
Sionna Therapeutics (Issuer)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:46 PM
Sionna Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2025
11:15 PM
Sionna Therapeutics (Filer)
Form EFFECT
02/06/2025
8:36 PM
COULTER JAMES G (Reporting)
Sionna Therapeutics (Issuer)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:18 PM
McKee Charlotte (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:18 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:22 PM
Sionna Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:06 PM
Sionna Therapeutics (Issuer)
Thompson Peter A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:07 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:09 PM
Cloonan Michael (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:12 PM
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:15 PM
Ruddy Marcella K. (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:15 PM
Iancovici Lucian (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
7:58 PM
Booth Bruce (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:00 PM
Ridloff Elena (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:02 PM
Clancy Paul J (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:02 PM
Fleming Harold Edward (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:05 PM
Resnick Joshua (Reporting)
Sionna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
8:05 PM
Sionna Therapeutics (Issuer)
Viney Joanne L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
6:00 PM
Sionna Therapeutics (Filer)
Form S-1MEF
02/06/2025
10:56 AM
Sionna Therapeutics (Filer)
Form CERT
02/04/2025
3:07 PM
Sionna Therapeutics (Filer)
Form 8-A12B
02/03/2025
5:06 AM
Sionna Therapeutics (Filer)
Form S-1/A
01/17/2025
4:00 PM
Sionna Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SION) was last updated on 2/24/2025 by MarketBeat.com Staff
From Our Partners